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Abstract 
Granulocyte-macrophage colony stimulating factor (GM-CSF) promotes the growth, survival, 
differentiation and activation of normal myeloid cells and is essential for fully functional 
macrophage differentiation in vivo. To better understand the mechanisms by which growth 
factors control the balance between proliferation and self-renewal versus growth-suppression 
and differentiation we have used the bi-potent FDB1 myeloid cell line, which proliferates in 
IL-3 and differentiates to granulocytes and macrophages in response to GM-CSF. This 
provides a manipulable model in which to dissect the switch between growth and 
differentiation. We show that, in the context of signaling from an activating mutant of the 
GM-CSF receptor  subunit, a single intracellular tyrosine residue (Y577) mediates the 
granulocyte fate decision. Loss of granulocyte differentiation in a Y577F second-site mutant 
is accompanied by enhanced macrophage differentiation, accumulation of -catenin together 
with activation of Tcf4 and other Wnt target genes. These include the known macrophage 
lineage inducer, Egr1. Further, we show that forced expression of Tcf4 or a stabilised -
catenin mutant is sufficient to promote macrophage differentiation in response to GM-CSF, 
and that GM-CSF can regulate -catenin stability. This study therefore identifies a novel 
pathway through which growth factor receptor signalling can interact with transcriptional 
regulators to influence lineage choice during myeloid differentiation. 
 
 
1
 
 
                                                 
Abbreviations: GM, granulocyte macrophage; GMR, GM-CSF receptor; DC, dendritic cell; IPA, ingenuity 
pathway analysis; BIO, (2’Z,3’E)-6-Bromoindirubin-3’-oxime 
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Introduction 
In this study we examine the process of granulocyte and macrophage lineage specification 
mediated via Granulocyte-macrophage colony stimulating factor (GM-CSF) signaling. GM-
CSF is a hematopoietic growth factor that can provide both permissive and instructive signals 
for myeloid differentiation (Kondo et al., 2000) and has been shown to play a critical role in 
DC function (Conti and Gessani, 2008). In vivo administration of GM-CSF promotes 
increased production of granulocytes and macrophages demonstrating its key role in vivo in 
driving coordinated proliferation and differentiation of GM progenitors (Metcalf et al., 1987). 
In particular, under steady-state conditions, GM-CSF signaling has a non-redundant role in 
mature macrophage production, with loss of GM-CSF signaling in mouse and humans 
leading to pulmonary alveolar proteinosis due to defects in alveolar macrophages (Dranoff et 
al., 1994; Suzuki et al., 2008; Martinez-Moczygemba et al., 2008; Nishinakamura et al., 
1995). Null animals also display compromised antigen-specific and LPS-induced T-cell 
responses and IFN production, which may be DC-mediated, have defects in macrophage 
function and are susceptible to various infectious agents (Enzler et al., 2003; Paine et al., 
2000). The high affinity receptors for human GM-CSF (GMR), IL-3 (IL3R) and IL-5 (IL5R) 
are each comprised of unique ligand-specific  subunits (GMR, IL3R or IL5R) and a 
shared  subunit (hc) which are all members of the cytokine receptor superfamily (for 
review see (Miyajima et al., 1993; Lopez et al., 2010). Each ligand binds to its specific -
subunit to form a low affinity intermediate which we, and others have shown to form a 
signaling complex that is likely to include a dimer of hc  and, at least in the case of the 
GMR, has been recently shown to form a higher order dodecameric complex for the full 
range of ligand induced signaling (McClure et al., 2001; McClure et al., 2003; Hansen et al., 
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2008). hc is the primary signaling subunit and mutation can result in constitutive activation 
with a range of mutants now described that display alternative phenotypes and signaling 
profiles (D'Andrea et al., 1998; McCormack and Gonda, 1999; Jenkins et al., 1995; Brown et 
al., 2004; Perugini et al.; 2010).   
   
Mutational studies of the GMR have identified intracellular regions and key residues of the 
GMR and hc that are responsible for the signaling required for myeloid differentiation 
versus growth. In particular, the region of hc containing Tyr577 is important for mediating 
GM-CSF induced myeloid differentiation of M1 and WEHI-3B D+ cells, where macrophage 
differentiation is induced in response to ligand, however particular residues in this region 
were not linked to the response (Smith et al., 1997). Studies with activated mutants of hc, 
showing reduced signaling complexity compared to the wild type receptor, have facilitated 
dissection of signaling networks downstream of the GM-CSF receptor, and allowed particular 
signaling events to be assigned to cellular outcomes (Brown et al., 2004; Perugini et al., 
2010; Jenkins et al., 1998). In this study we use the well-characterised activated hc mutant, 
FI, and a second-site mutant with a tyrosine to phenylalanine substitution at position 577 
(Y577F) that selectively abolishes granulocyte differentiation and enhances macrophage 
differentiation (Brown et al., 2004).  This has provided a model system in which to dissect 
GM differentiation induced through the GM-CSF receptor. The Tyrosine 577 residue of hc 
has been previously shown to be a key signaling residue associated with binding of the Shc 
adapter molecule and is part of a small phosphorylation-dependent motif, which regulates 
alternative survival and proliferation pathways (Okuda et al., 1997; Powell et al., 2009; 
Guthridge et al., 2006; Ramshaw et al., 2007). Here we focus on defining downstream events, 
associated with the Tyr577 residue, and on linking these to the lineage-fate choice between 
granulocyte and macrophage differentiation. We show that the Y577F mutation is associated 
with enhanced -catenin protein accumulation and Tcf4 gene expression and we demonstrate 
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 5 
a central role for these factors in promoting macrophage differentiation at the expense of 
granulocyte differentiation.  
Materials and Methods  
Cell culture 
The culture conditions of FDB1 cells, the construction of FI and FIY577F retroviral 
expression plasmids, and the generation of stable cell lines have been previously described 
(Brown et al., 2004). Before treatment of cells with inhibitors, cells were washed 3 times and 
starved of growth factor for 16 hours in medium containing serum. Stimulation was carried 
out for 5 minutes at 37°C by the use of 500 bone marrow units (BMU)/mL mouse (m)IL-3 or 
mouse (m)GM-CSF. The GSK-3 Inhibitor IX , BIO, and control, MeBIO, (Merk Chemicals, 
Nottingham, UK) were dissolved in DMSO and used at a final concentration of 2 M.  
 
Microarray hybridisation and analysis  
FDB1 cells expressing either FI and FIY577F were washed 3 times to remove growth 
factor and a proportion of cells were harvested at time zero. Cells were then cultured without 
factor for 72 hours for the second time point. Two biological replicates were prepared for 
each cell line (supplemental Fig. 1). Comparisons were performed for each cell line over time 
and direct comparisons between cell lines done at 0 and 72 hours. Additional dye swaps were 
done with the FI/ FIY577F 0 hour direct comparison and the FI 0-72 hour comparison 
(supplemental Fig. 2). RNA preparation and microarray analysis and hybridisation were 
performed as described previously (Brown et al., 2006). Lineage specific gene lists were 
defined as follows. Neutrophil associated genes were defined as genes with a significant 
change over time in FI expressing cells (p<0.001) but not FIY577F cells. Macrophage 
associated genes were defined as those with a significantly larger fold change over time in 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 6 
FIY577F cells compared to FI cells (p<0.001, supplemental Fig.2). We performed gene-
set enrichment analysis as previously described (Brown et al., 2006). Briefly, to test for 
association of published TF target gene sets based on either differential expression (C/EBP) 
(Gery et al., 2005) or ChIP (TCF and -catenin) (Hatzis et al., 2008; Yochum et al., 2007) 
with our data sets, we used the non-parametric Wilcoxon rank sum test as implemented in the 
R statistical program (http://www.r-project.org/). We constructed our reference set of genes 
based on ranking the FDR p-value for comparisons of reference-set and test-set. For the 
C/EBP comparison we generated a reference set by ranking all of the genes on our array 
using the FDR p-values for the change in expression over time in FI expressing cells and 
examined the distribution of C/EBP target genes in our reference list. For the -catenin and 
TCF4 comparisons we generated a reference set by ranking all of the genes on our array 
using FDR p-values for the change in expression over time in FIY577F expressing cells and 
examined the distribution of -catenin and TCF4 target genes in our reference list. A 
significant result from the Wilcoxon rank sum test indicated that the gene-set of interest 
displays an association with the indicated reference-set. Unsupervised clustering and 
heatmaps of data were generated with MeV (http://www.tm4.org/mev/). The raw microarray 
data is available in the Gene Expression Omnibus (GSE25857). 
QRT-PCR 
FDB1 cells expressing either FI and FIY577F were washed 3 times to remove growth 
factor and a proportion of cells were harvested at time zero. Cells were then cultured without 
factor and cells harvested at 24 hours and 72 hours. Parental FDB1 cells were also cultured in 
GM-CSF and harvested at 24, 72 and 120 hours. Two biological replicates of this experiment 
were performed. RNA was prepared using Trizol reagent (Invitrogen, Carlsbad, CA, USA) as 
per the manufacturers instructions. cDNA was prepared using the QuantiTect Reverse 
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 7 
Transcription Kit (Qiagen, Valencia, CA, USA). The sequences of the oligonucleotides used 
for PCR are listed in supplemental Table 1. Gene-specific PCR reactions were performed for 
40 cycles using FastStart Taq (Roche diagnostics, Indianapolis, IN, USA) and recommended 
conditions. SYBR green (Invitrogen, Carlsbad, CA, USA) was added to a final concentration 
of 0.6x per reaction and PCR was performed on the Rotor-Gene 6000 and related software 
used for data collection and to determine mean expression values relative to beta-actin 
(Corbett Research, Version 5.0, Qiagen, Valencia, CA, USA). Amplification products were 
analyzed by melt curve and sequenced to confirm specificity. 
Construction of retroviral expression plasmids and transduction of FDB1 cells 
Constructs for FLAG-tagged full length TCF4 and N-TCF4 in pcDNA3.1/Zeo were 
obtained from Hans Clever (van de et al., 2002). The cDNAs were amplified from the 
constructs using the oligos indicated in supplemental Table 1.  The products were digested 
with SfiI and ligated into SfiI digested murine stem cell virus (MSCV)-internal ribosome 
entry site (IRES)-green fluorescence protein (GFP) retroviral vector (modified to contain SfiI 
sites in the MCS).  The construct for stabilised -catenin (pCS2MMBCS33A) was obtained 
from Rolf Kemler (Rottbauer et al., 2002). The -catenin cDNA contains 4 amino acid 
substitution mutations (Ser33Ala, Ser37Ala, Thr41Ala and Ser45Ala).-catenin was 
amplified using the oligos indicated in supplemental materials and methods and cloned into 
MSCV-IRES-GFP as described above.  
Virus production and FDB1 transduction was performed as previously described (Perugini et 
al., 2009). For the TCF constructs, cells expressing GFP were sorted using flow cytometry 
and allowed to recover overnight before using in assays. For the catS33A construct, cells 
expressing GFP were sorted to generate a line with stable catS33A expression. Cell sorting 
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 8 
was performed on Beckman-Coulter ALTRA (Beckman-Coulter, Brea, CA, USA) or Becton-
Dickinson ARIA cell sorters (Becton-Dickinson, Franklin Lakes, NJ, USA). 
 
Proliferation and differentiation assays 
Growth was assessed using either CellTiter 96 AQueous One Solution Cell Proliferation 
Assay (Promega, Madison, WI, USA), or trypan blue exclusion. The proportion of viable 
cells was determined by trypan blue exclusion. To assess differentiation, cytospin 
preparations were made, and slides stained with May-Grünwald Giemsa. 200 cells were 
scored microscopically for morphology. In addition, cell surface staining was performed 
using a rat anti-mouse cfms-PE conjugate and isotype control, IgG2a-PE, from eBiosciences 
(San Diego, CA, USA) and analyzed by flow cytometry  using a FC500 or XL-MS analyser 
(Beckman-Coulter, Brea, CA, USA).   
 
Western immunoblot analysis and antibodies 
Cells were lysed in modified RIPA lysis buffer, separated by sodium dodecyl sulfate (SDS)–
polyacrylamide gel electrophoresis, and transferred to nitrocellulose. Proteins of interest were 
detected by use of the appropriate antibodies and SuperSignal West Pico, West Dura or West 
Femto substrates (Pierce Biotechnology, Thermo Scientific, Rockford, IL, USA). Mouse 
monoclonal anti--catenin was purchased from BD Biosciences (Becton-Dickinson, Franklin 
Lakes, NJ, USA). Rabbit polyclonal p38MAP Kinase and rabbit monoclonal 
GSK3antibody, were purchased from Cell Signaling Technology (Beverly, MA, USA). 
Secondary immunoglobulin G (IgG) antibodies were obtained from Pierce Biotechnology 
(Thermo Scientific, Rockford, IL, USA).  
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Online Supplemental Material 
Supplemental Table 1 includes sequences for oligonucleotides used for PCR and cloning. 
Supplemental Table 2 includes full lists of genes differentially regulated in macrophage and 
granulocyte lineages by Y577. Supplemental Table 3 includes the full list of -catenin/Tcf4 
target genes differentially regulated by Y577. Supplemental Fig. 1 contains mutant hc 
expression and differentiation information for the cells used in the microarray analysis. 
Supplemental Fig. 2 contains microarray experimental design and volcano plots of genes 
differentially regulated by Y577. Supplemental Fig. 3 shows the gene set enrichment plot for 
-catenin/Tcf4 target genes in FI-Y577F regulated genes. 
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Results 
A single tyrosine residue in GMR is required for granulocyte differentiation: a model of 
GM-CSF-induced lineage specification.  
When cultured in GM-CSF, FDB1 cells form granulocytes and macrophages in 
approximately equal proportions and this can be mimicked in the absence of growth factor by 
ectopic expression of the hc FI activated mutant (McCormack and Gonda, 2000). To 
characterise the signaling pathways and downstream genes supporting granulocyte and 
macrophage differentiation induced by GMR we performed comparative gene expression 
profiling of the differentiation response for FDB1 cells expressing the FI mutant and its 
derivative FIY577F, which supports differentiation predominantly to macrophages (Brown 
et al., 2004). Cultures of FDB1 cells expressing the parental FI mutant or the Y577F 
derivative were cultured in the absence of growth factor for 72 hours and assessed for the 
expected morphological differentiation prior to RNA extraction (supplemental Fig. 1). 
Microarray hybridisation and processing was carried out on the Compugen Mouse Oligo 
Library (v2, 21,997 65mers comprising 21,587 unique genes) as previously described (Brown 
et al., 2006). The differential gene expression in each population was determined over this 
time period and gene expression changes associated with mutation of Tyr577 were 
determined by linear modelling (supplemental Fig. 2A) (Brown et al., 2006). Gene expression 
changes were defined as Tyr577-associated and involved in promoting granulocyte 
differentiation if the change in expression was selectively lost in cells responding to the 
FIY577 mutant (supplemental Fig. 2B). Genes with a significantly greater change over time 
in FIY577F compared to FI (supplemental Fig. 2B) were defined as suppressed by Tyr577 
signaling, and associated with promoting macrophage differentiation. Lists of differentially-
expressed genes were generated using an FDR p-value of 0.001 and a fold change cut-off of 
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1.4. Using this approach we identified 153 up-regulated and 83 down-regulated genes 
associated specifically with intact Tyr577 signaling and differentiation of the granulocyte 
lineage and 166 up-regulated and 55 down-regulated genes associated with enhanced 
differentiation of the macrophage lineage in the absence of Tyr577 signaling (supplemental 
Table 2). The top 25 up and down regulated genes associated specifically with the 
granulocyte and macrophage lineages are shown in Fig. 1A and C respectively.  
 
Consistent with the loss of neutrophil differentiation associated with the Y577 second-site 
mutant we identified differential expression of many known neutrophil genes amongst the 
Tyr577-regulated genes. These included granule proteins such as Ltf, Ngp, Mmp8, Itgb2l, 
Camp, Prtn3, Lcn2, Ceacam1, S100a8. Many of these genes are also targets of the C/EBP 
family of transcription factors several members of which, including C/EBP and C/EBP are 
important regulators of this lineage. Indeed, using gene-set enrichment analysis we identified 
a significant association of these genes with the C/EBP target gene-set generated by Gery et 
al (Gery et al., 2005) (p=0.00023). Ingenuity pathway analysis (IPA) of the full neutrophil 
associated gene list identified significantly associated canonical pathways. These revealed a 
network of down-regulated genes involved in IL-4 signaling (and T and B cell differentiation 
and function) consistent with suppression of some alternative lineages, and up-regulation of 
genes associated with leukocyte function (Fig. 1B).  
 
As predicted, the genes that show enhanced up-regulation over time in the presence of the 
Y577F mutation were strongly associated with macrophage differentiation. These included 
genes involved in macrophage function, such as proteins normally found in the lysosomal 
compartment of macrophages (e.g. Ctss, Psap, Mmp12, Asahl) or cell surface proteins 
involved in the innate immune response (e.g. Clecsf12, Clecsf10, Trem2, Ccr2, Itgax). Of 
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particular interest are known key regulators of macrophage differentiation such as CSF1 
receptor and ligand, PKC and the transcription factors Egr1, Fos and C/EBP all of which 
displayed large increases in expression selectively in the Y577F mutant over the 72 hour time 
course (Fig. 1C-D) IPA canonical pathway analysis identified pathways associated with 
rheumatoid arthritis, a disease with known GM-CSF induced macrophage involvement 
(Hamilton, 2008) (Fig. 1D). In addition, the macrophage associated gene list also contained 
genes significantly associated with pathways of PPAR, IL-6, p38MAPK, GM-CSF and IL-3 
signaling, that were not identified with the neutrophil associated gene list (Fig. 1B). Thus 
gene expression analysis using this FDB1 differentiation model is consistent with signaling 
from Tyr577 promoting a granulocyte differentiation program while suppressing key inducers 
of macrophage differentiation.  
 
Tcf4 is a repressed target of Tyr577 signaling and a promoter of macrophage 
differentiation 
Given that key regulators of macrophage differentiation are significantly up-regulated over 
time in cells expressing the FIY577 mutant we next used this characteristic pattern to 
identify additional potential regulators of macrophage differentiation. By microarray the 
transcription factor Tcf4 showed significantly enhanced up-regulation in cells expressing the 
Y577F second-site mutant of FI(FDR p=1.8x10-11, Fig. 1C). A comparison of the change in 
expression for Tcf4 and other macrophage lineage transcription factors (TFs) (Egr1, Fos and 
C/EBP) in FI and FIY577F expressing cells was determined by quantitative RT-PCR (Q-
PCR) and is shown in Fig. 2A. The expression changes of Tcf4, Egr1, Fos and Cebpb were 
consistent with the results obtained by microarray (Fig. 2A). Expression of these genes also 
increases during GM-CSF-directed  bi-lineage terminal differentiation of FDB1 cells (which 
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proceeds more slowly than FI-induced GM differentiation) over 120 hours (Fig. 2B).  By 
QPCR Tcf4 mRNA expression increased from 1.8 fold at 72 hours in FI cells to 7 fold in 
FIY577F cells and by 3.8 fold in GM-CSF-treated parental FDB1 cells at 72 hours (Fig. 2 
A,B). This is consistent with Tcf4 being a repressed target of the Y577 signaling pathway 
with a potential role in promoting macrophage differentiation and/or suppressing granulocyte 
differentiation. Tcf4 is itself a target gene activated by the Tcf4/-catenin complex (Hatzis et 
al., 2008) and up-regulation of Tcf4 expression is likely to be an indication of Wnt pathway 
activation. Further support for this was provided from IPA pathway analysis which identified 
an association between the genes associated with Tyr577 signaling and the Wnt/-catenin 
pathway, in particular up-regulation of Tcf4, as well as down-regulation of the Wnt 
antagonist Dkkl1 (Fig. 1D).  
 
Tcf4 is a DNA-binding cofactor of -catenin and a role for Tcf4 has not previously been 
reported in promoting myeloid differentiation. To further investigate the possibility that -
catenin/TCF4 is involved in promoting macrophage differentiation in FDB1 cells we 
ectopically expressed full length Tcf4 and Tcf4 lacking the amino terminal -catenin 
interaction domain (N-Tcf4; Fig. 2C) using the MSCV-IRES-GFP (MIG) vector (Fig. 2D-
F). FDB1 cells were transduced with MIG-Tcf4, MIG-N-Tcf4 or MIG vector control and 
infected cells (GFP+) enriched by flow cytometry. After sorting, cells were seeded into 
medium containing IL-3 (for growth) or GM-CSF (GM differentiation) and growth, viability 
and differentiation were measured over a 5 day period. Expression of Tcf4 resulted in 
significantly reduced growth over 5 days in both IL-3 and GM-CSF (Fig. 2D) which was also 
associated with significantly reduced viability (as measured by trypan blue exclusion) at day 
5 in IL-3, but not GM-CSF (data not shown). Interestingly, while N-Tcf4 was also able to 
affect the growth of cells in IL-3, there was no effect on cell expansion in response to GM-
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CSF (Fig. 2D) indicating that the latter effect is dependent on the -catenin interaction 
domain. The Tcf4 and N-Tcf4 growth suppression in IL-3 was associated with a 
significantly decreased number of blasts and an increase in the number of granulocytes, 
although the majority of cells in IL-3 in all cases were still of undifferentiated morphology 
(Fig. 2E). Importantly, under conditions of GM-CSF-induced differentiation, we found that 
ectopic Tcf4 expression significantly increased the number of cells differentiating to 
macrophages, a response that was not associated with expression of the N-Tcf4 mutant (Fig. 
2E). This enhanced macrophage differentiation was also associated with increased cell 
surface expression of the macrophage marker, c-fms (Fig. 2F). These results show that Tcf4 
has the capacity, most likely via an interaction with -catenin, to promote differentiation of 
the macrophage lineage.  
 
GM-CSF receptor activation induces -catenin stabilization that is negatively regulated 
by the Tyr577 pathway 
We next determined the levels of -catenin protein present in FDB1 cells expressing the FI 
mutant or the Y577F derivative, or responding to GM-CSF over 72 hours. In cells responding 
to GM-CSF or expressing FI we observed accumulation of -catenin at 24 hours following 
IL-3 withdrawal, which was absent at 72 hours (Fig. 3A). In contrast, in cells expressing 
FIY577F, which differentiate predominantly to macrophages, -catenin was constitutively 
present (Fig. 3A). This is consistent with mutation of Tyr577 disrupting a pathway that 
normally regulates the stability of -catenin. To further examine the pathway regulating -
catenin stabilization we treated FDB1 cells with the Glycogen synthase kinase 3 (GSK3 
inhibitor BIO. GSK3 is a well-recognised negative regulator of -catenin stability and one 
of the characterised effects of inhibition of GSK3 activity is constitutive -catenin protein 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 15 
stabilisation (Liu et al., 2002; Holmes et al., 2008). Parental FDB1 cells were treated with 2 
µM BIO or the control N-methylated analogue (Me-BIO). As predicted, inhibition of GSK3 
with BIO led to increased -catenin protein levels measured at 16 hours (Fig. 3B). BIO 
treatment did not significantly affect viability of the cells, as measured by trypan blue 
exclusion (data not shown) but resulted in a significant suppression of growth in response to 
both IL-3 and GM-CSF (Fig. 3C). In response to GM-CSF, there was a significant increase in 
the number of macrophages with concomitant decreases in both blasts and granulocytes (Fig. 
3D). This was also associated with a clear increase in the number of cells expressing c-fms 
(Fig. 3E). We also observed increased levels of macrophages in response to IL-3 in the 
presence of BIO although this increase was not significant.  
-catenin stabilization is sufficient to specify macrophage differentiation in FDB1 cells 
We next tested the ability of -catenin to directly mediate macrophage differentiation by 
ectopically expressing a stabilized form of -catenin. For this we used the MIG vector to 
express an engineered version of -catenin containing point mutations at the GSK3 and 
casein kinase phosphorylation sites (Ser33Ala, Ser37Ala, Thr41Ala, Ser45Ala) (Liu et al., 
2002; Rottbauer et al., 2002). Expression of this -catenin mutant (herein referred to as 
catS33A) has previously been shown to render the -catenin protein resistant to degradation 
and consequently mimic a constitutive Wnt signal (Aoki et al., 2002; Rottbauer et al., 2002). 
FDB1 cells were transduced with MIG-catS33A or MIG vector control and infected cells 
(GFP+) enriched by flow cytometry. After sorting, cells were seeded into medium containing 
IL-3 or GM-CSF and growth, viability and differentiation were measured over a 5 day period. 
Western immunoblot analysis at day 5 confirmed the increase of -catenin protein in cells 
transduced with MIG-catS33A, in both IL-3 and GM-CSF (Fig 4A). Over-expression of 
catS33A did not affect growth of FDB1 cells in IL-3, however in the presence of GM-CSF 
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we observed significantly enhanced growth of the MIG-catS33A FDB1 cell population (Fig. 
4B). There was no difference in the viability of the cell populations (as measured by trypan 
blue exclusion) over the 5 day period (data not shown). Importantly, after 5 days in GM-CSF, 
differentiation of the MIG-catS33A cell population was associated with a significantly 
increased proportion of macrophages (p=0.027) compared to vector-control cells (Fig. 4C-D). 
While having a significant effect on differentiation in GM-CSF, catS33A was not sufficient 
to induce differentiation to macrophages in the presence of IL-3 (Fig. 4C-D). Taken together 
with the BIO-induction of differentiation this demonstrates that, in the context of GM-CSF 
signaling, stabilization of -catenin promotes specification of macrophage differentiation in 
this FDB1 model system.  
 
Tcf4/-catenin target genes are enriched in Tyr577-regulated genes 
To further investigate the link between Tyr577 signaling, Tcf4/-catenin activity and 
macrophage differentiation we investigated whether other known -catenin/Tcf4 target genes, 
are regulated in response to Tyr577 signaling. For this we used gene-set enrichment analysis 
to compare the full set of Y577-differentially regulated genes with a combined gene-set of 
direct TCF4 and -catenin target genes (347 genes) derived from two chromatin 
immunoprecipitation (ChIP) studies in colorectal cancer cell lines (Hatzis et al., 2008; 
Yochum et al., 2007). This analysis identified a significant association between the 347 -
catenin/Tcf4 target genes and the genes significantly differentially regulated over time by 
FIY577F (p=1.7x10-11, Wilcoxon rank-sum test, supplemental Fig. 3). The full list of 
significantly differentially expressed -catenin/TCF4 targets (113 genes) is shown in 
supplemental Table 2. This analysis showed a clear association of the Tyr577-regulated genes 
with -catenin and Tcf4 direct target genes. Egr1 is the -catenin/Tcf4 direct-target gene with 
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the largest-fold differential expression in FIY577F expressing cells over time suggesting a 
key macrophage promoting role for this lineage-specific TF downstream of the Tyr577 
signaling pathway. Differential regulation of Egr1 in the FIY577F mutant was also 
validated by QPCR (Fig. 2A). As shown in Fig. 5 Egr1, although not specified by IPA as a 
Wnt/-catenin signaling-related gene, an identified ChIP target of the -catenin/TCF4 
complex (Yochum et al., 2007) and is independently connected to multiple -catenin/Tcf4 
targets, consistent with a model of macrophage differentiation that involves Wnt/-catenin 
modulation of Egr1 activity (Fig. 6).  
Discussion 
While genetic and functional studies provide clear evidence for the importance of GM-CSF 
signaling in macrophage differentiation, the pathways that contribute to this process are still 
incompletely defined. Here we define a novel signaling pathway from the GM-CSF receptor 
that we propose contributes to the lineage fate of bi-potential GM progenitors. The key 
intracellular Tyr577 residue in the common  subunit of the GM-CSF receptor has been 
shown previously to be a determinant of the extent of granulocyte and macrophage 
differentiation in the FDB1 cell line model (Brown et al., 2004). An in vivo mutant model of 
Tyr577 signaling also showed expansion of progenitor cells in response to GM-CSF 
consistent with a defect in GM progenitor differentiation (Ramshaw et al., 2007). Our 
analysis comparing gene expression in the activated (FI) mutant of GMR, that mediates 
factor-independent macrophage and granulocyte differentiation, with that of the second-site 
mutant FIY577F, is consistent with the observed reduction in morphological granulocyte 
differentiation upon mutation of Tyr577 (Brown et al., 2004). Here we focused on Tcf4 which 
displayed similar expression to other regulators of macrophage differentiation in the FDB1 
system (Fig. 2). Tcf4 is a member of the Tcf/Lef family that combines with -catenin to form 
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transcriptional complexes that regulate target gene transcription. The Tyr577 mutation results 
in increased Tcf4 expression and is associated with reduced granulocyte differentiation and 
enhanced differentiation to the macrophage lineage. Our data are most consistent with Tcf4 
functioning as a promoter of differentiation and tumour suppressor in the GM lineage. Forced 
expression of Tcf4 in FDB1 cells responding to GM-CSF demonstrated a functional role in 
promoting macrophage differentiation. This effect was dependent on the -catenin interaction 
domain, consistent with the known interaction and cooperation between Tcf4 and -catenin.   
 
Activation of Tcf4 transcription downstream of GMR is most likely a result of -catenin 
accumulation as Tcf4 is itself a target gene of the Tcf4/-catenin transcriptional complex 
(Hatzis et al., 2008). We found that -catenin accumulated in the presence of the FIY577F 
mutant. We also observed transient accumulation of -catenin at the 24 hour timepoint 
following GM-CSF stimulation of FDB1 cells (Fig. 3A) and expression of a stabilised -
catenin or inhibition of GSK3 with pharmacological inhibitors mimicked Tcf4 over-
expression and increased the number of cells differentiating to macrophages. Thus three 
independent approaches demonstrate that -catenin/Tcf4 activity promotes macrophage 
differentiation in the FDB1 system. The ability of BIO to stabilize -catenin downstream of 
GM-CSF signalling suggests that, as in other systems, GSK3 is key to regulating -catenin 
protein levels and therefore activation of this pathway in response to GM-CSF. Modification 
of GSK3 signalling by the GMR has not been previously investigated and although not 
directly shown here, the accumulation -catenin in cells expressing the FIY577F mutant 
suggests that this residue may normally have a role in regulating GSK3 activity in response 
to GM-CSF. Previous studies have linked Tyr577 to binding of Shc and activation and 
regulation of Gab2, Akt/PI3K and SHIP related pathways (Gu et al., 2000; Dijkers et al., 
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1999; Ramshaw et al., 2007). Interestingly, mutation of this residue in different contexts has 
been associated with both reduced and enhanced activation of Akt (Dijkers et al., 1999; 
Ramshaw et al., 2007). Preliminary analysis of signalling from FI and FIY577F in FDB1 
cells suggests alterations in activation of both Akt and p38MAPK (data not shown) both of 
which are known regulators of the GSK3/-catenin axis (Liu et al., 2002; Cross et al., 1995; 
Thornton et al., 2008; Bikkavilli et al., 2008). Further mapping of this pathway downstream 
of the GM-CSF receptor in this cell line model will reveal the signalling events important for 
macrophage differentiation and modulation of -catenin activity, and shed light on the 
interplay between growth factor receptor signalling and transcriptional regulation in myeloid 
differentiation. 
 
While a role for -catenin in stem cell function and progenitor commitment has been reported 
previously (Zhao et al., 2007), our observation of a differentiation-promoting and lineage 
modulation capacity represents a novel function for Tcf4/-catenin in the hematopoietic 
system. Activation of -catenin in response to M-CSF signaling supports the growth and 
survival of macrophages, consistent with our findings, although lineage specification was not 
examined in this context (Otero et al., 2009). Interestingly we also note that conditional 
activation of -catenin in the hematopoietic system acts to reduce the number of GM 
progenitors, and colonies formed in response to GM-CSF overall, and blocks granulocyte 
colony formation completely, while maintaining permissive conditions for some macrophage 
colony formation (Scheller et al., 2006). These data support our hypothesis that -catenin 
may have independent roles at different stages of haemopoiesis, including a role in 
committed progenitors for determining macrophage versus granulocyte differentiation 
decisions. To shed light on the possible mechanism of -catenin/Tcf4 mediated macrophage 
differentiation we analysed the Tyr577-regulated genes and showed a significant enrichment 
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of -catenin/TCF4 target genes.  Of particular note was the known transcriptional mediator of 
macrophage differentiation, Egr1 which displayed an 8-fold increase in expression over 72 
hours during FIY577F-induced macrophage differentiation and was the most significant 
differentially regulated macrophage-associated gene. In primary myeloid progenitors Egr1 is 
controlled by the macrophage master regulator PU.1 and induction of Egr1 promotes the 
transcription of macrophage genes, while repressing the alternative granulocyte lineage 
associated genes (Laslo et al., 2006). This provides a likely mechanism by which -
catenin/Tcf4 could influence macrophage differentiation. Recent reports have shown that 
Egr1 directly regulates Tcf4 in endometrial carcinoma cells and link Egr1 expression to 
progression of colorectal cancer, a process which also involves -catenin/Tcf4 (Saegusa et 
al., 2008; Ernst et al.), suggesting the possibility of a positive feedback loop. Interestingly 
like -catenin, Egr1 is also important for hematopoietic stem cell homeostasis (Min et al., 
2008; Zhao et al., 2007) suggesting that this regulatory loop may operate with different 
outputs at the level of the HSC and the committed myeloid progenitor. Further dissection of 
these roles will require stage or lineage specific deletion approaches to separate stem cell 
effects from those important for later cell fate decisions and will shed light on their role in 
GM lineage choice.  
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Figure Legends  
Fig. 1. Y577 regulated genes 
A. Heatmap showing the expression of the top 25 up and down regulated genes associated 
FI induced factor independent granulocyte differentiation over 72 hours (see materials and 
methods for details of gene-set derivations). B. IPA defined canonical pathways significantly 
associated with the neutrophil gene set Lysine= lysine degradation, LES= leukocyte 
extravasation signaling, CES= caveolar-mediated endocytosis signaling. C. Heatmap 
showing the expression of the top 25 up and down regulated genes associated with FI-
Y577F induced factor independent macrophage differentiation over 72 hours. D. IPA defined 
canonical pathways associated with the macrophage gene set, AP= acute phase response 
signaling, RA= rheumatoid arthritis. The M value (log2 fold change) for both FI or 
FIY577F expressing cells was converted to a colour scale with red indicating that gene 
expression increases between 0 and 72 hours and green indicating that the gene expression 
decreases with the colour intensity indicating the magnitude of regulation (range log2, -3 to 
+3). Black boxes indicate individual genes involved in the indicated pathway. Tcf7l2=Tcf4. 
 
Fig. 2. Tcf4  is regulated by GM-CSF and promotes macrophage differentiation  
Quantitative real-time PCR was used to determine the expression of the indicated genes. 
Expression was normalised to -actin and expression is shown relative to 0 hours. Results 
shown are the average of two experiments A. FDB1 cells expressing FI and FIY577F were 
cultured without factor and RNA extracted at 0, 24 and 72 hours. B. Parental FDB1 cells 
were culture in GM-CSF and RNA extracted at 0, 24, 72 and 120 hours. C. Full length TCF4 
and the engineered form lacking the N-terminal -catenin interaction domain are depicted. 
The -catenin interaction domain is indicated by a black box and the DNA binding domain is 
indicated by a grey box. D. FDB1 parental cells were transduced with a MSCV-IRES-GFP 
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retrovirus encoding TCF4, N-TCF4 or a control retrovirus and selected for GFP expression 
by FACS. Cells were washed and placed in the indicated growth conditions. Expansion of 
GFP positive cells was determined by assessing viable cell number using trypan blue 
exclusion and flow cytometry to determine the proportion of GFP positive cells at the 
indicated time points. E. At day 5, cells were cytocentrifuged, Wright-Giemsa stained and 
200 cells for each condition were scored microscopically for morphology. F. At day 5 cells 
were stained with PE-conjugated anti-c-fms and the percentage of c-fms positive cells in the 
GFP positive population was determined for each cell line. A representative flow histogram is 
shown. Error bars represent SEM (n=4) and *=p<0.05, **=<0.01, ***=p<0.001 (unpaired, 
two sided t-test). 
 
Fig. 3. -catenin stabilization is associated with increased macrophage differentiation 
A. FDB1 cells expressing FI and FIY577F were cultured without factor and parental cells 
in GM-CSF and cell lysates were made at 0, 24 and 72 hours. Lysates were western blotted 
with the indicated antibodies. Representative photo-micrographs were taken at the 72 hour 
timepoint for FDB1 FI and FIY577F cells and at 120 hours for parental cells in GM-CSF. 
B. FDB1 cells growing in response to IL-3 or undergoing GM differentiation in response to 
GM-CSF were incubated with 2 M of the GSK3 inhibitor BIO ((2’Z,3’E)-6-
Bromoindirubin-3’-oxime) or N-methylated control analogue (Me-BIO). Activity of BIO at 
16 hours was assessed by detection of -catenin protein by western analysis. C. Cell growth 
was determined at days 2 and 5 of GSK3 inhibition by trypan blue exclusion. D. At day 5 
cells were cytocentrifuged, Wright-Giemsa stained and 200 cells for each condition were 
scored microscopically for morphology. E. At day 5 cells were stained with PE-conjugated 
anti-c-fms and the percentage of c-fms positive cells was determined for each cell population. 
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Error bars represent SEM (n=3) and *=p<0.05, **=<0.01, ***=p<0.001 (unpaired, two sided 
t-test). 
 
Fig. 4. -catenin directs macrophage differentiation in response to GM-CSF receptor 
signaling 
 FDB1 cells were transduced with MIG encoding -catenin with mutations S33A, S37A, 
T41A, S45A (catS33A) or vector alone. A. GFP positive cells were placed in IL-3 or GM-
CSF and after 5 days were assessed for expression of stabilised -catenin by western 
analysis. B. Growth was assessed over 4 days using AQueous one solution proliferation 
assay. C. At day 5 cells were cytocentrifuged, Wright-Giemsa stained and 200 cells for each 
condition were scored by morphology. Error bars represent SEM (n=2) and *=p<0.05 
(unpaired, two sided t-test). D. Photomicrographs of cells at day 5. 
 
Fig. 5. A TCF4/-catenin target gene network in FIY577F regulated genes 
A. The overlapping TCF4/-catenin and macrophage genes with an FDR p<0.05 (113) were 
subjected to Ingenuity Pathway Analysis (IPA). The genes were subject to IPA mapping of 
network interactions and filtered for direct interactions and networks containing genes 
identified as involved in Wnt/-catenin signaling. The colour indicates the direction of 
differential expression in our macrophage regulated gene list with red indicating that gene 
expression increases between 0 and 72 hours and green indicating that the gene expression 
decreases with the colour intensity indicating the magnitude of regulation. CTNNB1= -
catenin. 
Fig. 6. Novel molecular interactions in monopoiesis regulated by GM-CSF signaling 
Signaling emanating from Tyr577 of the GMR leads to stabilisation of the -catenin protein 
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(possibly though GSK3 inactivation) which, in combination with Tcf4, leads to 
differentiation of the macrophage lineage at the expense of neutrophil lineage. 
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